219 related articles for article (PubMed ID: 9617842)
1. A novel ELISA for the evaluation of the classical pathway of complement.
Zwirner J; Wittig A; Kremmer E; Götze O
J Immunol Methods; 1998 Feb; 211(1-2):183-90. PubMed ID: 9617842
[TBL] [Abstract][Full Text] [Related]
2. The effect of aging on complement activity (CH50) and complement protein levels.
Nagaki K; Hiramatsu S; Inai S; Sasaki A
J Clin Lab Immunol; 1980 Jan; 3(1):45-50. PubMed ID: 7381926
[TBL] [Abstract][Full Text] [Related]
3. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA.
Larsson A; Sjöquist J
J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142
[TBL] [Abstract][Full Text] [Related]
4. Complement changes in falciparum malaria infection.
Phanuphak P; Hanvanich M; Sakulramrung R; Moollaor P; Sitprija V; Phanthumkosol D
Clin Exp Immunol; 1985 Mar; 59(3):571-6. PubMed ID: 3886219
[TBL] [Abstract][Full Text] [Related]
5. A novel ELISA for the assessment of classical pathway of complement activation in vivo by measurement of C4-C3 complexes.
Zwirner J; Dobos G; Götze O
J Immunol Methods; 1995 Oct; 186(1):55-63. PubMed ID: 7561148
[TBL] [Abstract][Full Text] [Related]
6. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
[TBL] [Abstract][Full Text] [Related]
7. [Components of the classical complement pathway in systemic lupus erythematosus].
Maillet F; Goetz J; Hauptmann G; Clauvel JP; Mery JP; Kahn MF; Kazatchkine M
Presse Med; 1987 Mar; 16(8):378-82. PubMed ID: 2950498
[TBL] [Abstract][Full Text] [Related]
8. Haemolytic complement in peripheral lymph of normal men.
Olszewski WL; Engeset A
Clin Exp Immunol; 1978 Jun; 32(3):392-8. PubMed ID: 99278
[TBL] [Abstract][Full Text] [Related]
9. The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency.
Høgåsen AK; Overlie I; Hansen TW; Abrahamsen TG; Finne PH; Høgåsen K
J Perinat Med; 2000; 28(1):39-48. PubMed ID: 10765513
[TBL] [Abstract][Full Text] [Related]
10. Assessment of complement activation in clinical samples. Comparison of immunochemical and functional measurements of complement components with quantitation of activation fragments.
Maillet F; Frémeaux-Bacchi V; Uhring-Lambert B; Kazatchkine MD
J Immunol Methods; 1992 Dec; 156(2):171-8. PubMed ID: 1474254
[TBL] [Abstract][Full Text] [Related]
11. New procedure for the detection of complement deficiency by ELISA. Analysis of activation pathways and circumvention of rheumatoid factor influence.
Fredrikson GN; Truedsson L; Sjöholm AG
J Immunol Methods; 1993 Dec; 166(2):263-70. PubMed ID: 8288879
[TBL] [Abstract][Full Text] [Related]
12. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
Sheĭtanov I; Nikolov K; Petrova P
Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
[TBL] [Abstract][Full Text] [Related]
13. [Glomerular localization of the early components of complement in glomerulonephritis].
Barbiano di Belgiojoso G; Tarantino A; Durante A; Guerra L
Minerva Nefrol; 1974; 21(3):169-78. PubMed ID: 4463297
[No Abstract] [Full Text] [Related]
14. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
[TBL] [Abstract][Full Text] [Related]
15. The significance of complement in proliferative vitreoretinopathy.
Grisanti S; Wiedemann P; Weller M; Heimann K; Zilles K
Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2711-7. PubMed ID: 1894471
[TBL] [Abstract][Full Text] [Related]
16. [Hereditary complement deficiencies].
Fischer E
Hautarzt; 1982 Feb; 33(2):65-72. PubMed ID: 6281215
[TBL] [Abstract][Full Text] [Related]
17. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
[TBL] [Abstract][Full Text] [Related]
18. Testing of hemolytic complement components in domestic animals.
Barta O; Hubbert NL
Am J Vet Res; 1978 Aug; 39(8):1303-8. PubMed ID: 697137
[TBL] [Abstract][Full Text] [Related]
19. Influence of age and sex on serum complement components in children.
Roach B; Kim Y; Jerome E; Michael AF
Am J Dis Child; 1981 Oct; 135(10):918-20. PubMed ID: 6975036
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of circulating immune complexes quantity detection by three assays--CIF-ELISA, C1q-ELISA and anti-C3 ELISA.
Stanilova SA; Slavov ES
J Immunol Methods; 2001 Jul; 253(1-2):13-21. PubMed ID: 11384665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
